Synutra International, the Chinese infant formula manufacturer, has raised its full-year outlook having registered an increase in income from operations of more than 50% in the first half of the year.
The company said first-half income from operations increased 53% to US$37.9m for the first half of fiscal 2015, compared to $15.8m in the prior year. Net income attributable to Synutra stockholders was $28.2m for the six months, or $0.49 per share, compared to $10.8m, or $0.19 per share, last year.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The company said earnings were boosted by lower costs, with SG&A expenses falling from 27.4% of sales second quarter of last year, to 23.2% this year.
The bottom line also benefited from increased sales on higher volumes and a higher proportion of branded sales. Net sales for the first half increased to $188.44m, from $170.8m. Sales from branded powdered formula products increased to $175.0m, or 92.9% of net sales, compared to $139.7m, or 81.8% of net sales, in the prior year period.
Looking to the full-year, Synutra said sales are expected to grow by “at least” 20% to a range of $450-500m. Synutra raised its net income guidance from $50-60m to $55-65m, representing growth of “at least” 75% on last year’s profit levels.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData
